410 related articles for article (PubMed ID: 10792127)
1. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
Annibale B; Aprile MR; D'ambra G; Caruana P; Bordi C; Delle Fave G
Aliment Pharmacol Ther; 2000 May; 14(5):625-34. PubMed ID: 10792127
[TBL] [Abstract][Full Text] [Related]
2. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis.
Annibale B; Di Giulio E; Caruana P; Lahner E; Capurso G; Bordi C; Delle Fave G
Aliment Pharmacol Ther; 2002 Oct; 16(10):1723-31. PubMed ID: 12269964
[TBL] [Abstract][Full Text] [Related]
3. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
4. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
6. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
8. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
[TBL] [Abstract][Full Text] [Related]
9. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
Katelaris PH; Seow F; Lin BP; Napoli J; Ngu MC; Jones DB
Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948
[TBL] [Abstract][Full Text] [Related]
10. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.
Derakhshan MH; El-Omar E; Oien K; Gillen D; Fyfe V; Crabtree JE; McColl KE
J Clin Pathol; 2006 Dec; 59(12):1293-9. PubMed ID: 16644877
[TBL] [Abstract][Full Text] [Related]
11. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection.
Annibale B; Negrini R; Caruana P; Lahner E; Grossi C; Bordi C; Delle Fave G
Helicobacter; 2001 Sep; 6(3):225-33. PubMed ID: 11683925
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Ito M; Haruma K; Kamada T; Mihara M; Kim S; Kitadai Y; Sumii M; Tanaka S; Yoshihara M; Chayama K
Aliment Pharmacol Ther; 2002 Aug; 16(8):1449-56. PubMed ID: 12182744
[TBL] [Abstract][Full Text] [Related]
13. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
[TBL] [Abstract][Full Text] [Related]
14. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Chabannaya TA
Rocz Akad Med Bialymst; 2005; 50():183-7. PubMed ID: 16358962
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.
Rembiasz K; Konturek PC; Karcz D; Konturek SJ; Ochmanski W; Bielanski W; Budzynski A; Stachura J
Dig Dis Sci; 2005 Mar; 50(3):474-82. PubMed ID: 15810629
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
17. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
Di Mario F; Moussa AM; Dal Bò N; Caruana P; Pilotto A; Cavallaro LG; Cavestro GM; Iori V; Merli R; Franzé A; Rugge M
J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
Konturek PC; Konturek SJ; Bobrzyński A; Kwiecień N; Obtułowicz W; Stachura J; Hahn EG; Rembiarz K
J Physiol Pharmacol; 1997 Sep; 48(3):365-73. PubMed ID: 9376619
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
20. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
